68 related articles for article (PubMed ID: 2934760)
1. Osteoporosis in chronic cholestatic liver disease.
Stellon AJ; Davies A; Compston J; Williams R
Q J Med; 1985 Nov; 57(223):783-90. PubMed ID: 2934760
[TBL] [Abstract][Full Text] [Related]
2. Vertebral fractures are associated with increased cortical porosity in iliac crest bone biopsy of men with idiopathic osteoporosis.
Ostertag A; Cohen-Solal M; Audran M; Legrand E; Marty C; Chappard D; de Vernejoul MC
Bone; 2009 Mar; 44(3):413-7. PubMed ID: 19071239
[TBL] [Abstract][Full Text] [Related]
3. Bone geometry and density in the skeleton of pre-pubertal gymnasts and school children.
Ward KA; Roberts SA; Adams JE; Mughal MZ
Bone; 2005 Jun; 36(6):1012-8. PubMed ID: 15876561
[TBL] [Abstract][Full Text] [Related]
4. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
[TBL] [Abstract][Full Text] [Related]
5. Human parathyroid hormone 1-34 prevents bone loss in experimental biliary cirrhosis in rats.
Dresner-Pollak R; Gabet Y; Steimatzky A; Hamdani G; Bab I; Ackerman Z; Weinreb M
Gastroenterology; 2008 Jan; 134(1):259-67. PubMed ID: 18061175
[TBL] [Abstract][Full Text] [Related]
6. Fracture risk of women with primary biliary cirrhosis: no increase compared with general population controls.
Boulton-Jones JR; Fenn RM; West J; Logan RF; Ryder SD
Aliment Pharmacol Ther; 2004 Sep; 20(5):551-7. PubMed ID: 15339326
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in rural Thai adults living in Khon Kaen province.
Pongchaiyakul C; Rojroongwasinkul N; Chotmongkol R; Kosulwat V; Charoenkiatkul S; Rajatanavin R
J Med Assoc Thai; 2002 Feb; 85(2):235-44. PubMed ID: 12081125
[TBL] [Abstract][Full Text] [Related]
8. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss.
Parfitt AM; Mathews CH; Villanueva AR; Kleerekoper M; Frame B; Rao DS
J Clin Invest; 1983 Oct; 72(4):1396-409. PubMed ID: 6630513
[TBL] [Abstract][Full Text] [Related]
9. [Histomorphometry. Method for evaluating the bone mass].
Meunier PJ; Chavassieux P
Rev Rhum Mal Osteoartic; 1985 Dec; 52(12):669-73. PubMed ID: 4095470
[TBL] [Abstract][Full Text] [Related]
10. Is the amount of trabecular bone-loss dependent on bone mineral Density? A study performed by three centres of osteoporosis using high resolution peripheral quantitative computed tomography.
Radspieler H; Dambacher MA; Kissling R; Neff M
Eur J Med Res; 2000 Jan; 5(1):32-9. PubMed ID: 10657287
[TBL] [Abstract][Full Text] [Related]
11. The microanatomy of trabecular bone in young normal and osteoporotic elderly males.
Shahtaheri SM
Aging Male; 2007 Jun; 10(2):71-5. PubMed ID: 17558971
[TBL] [Abstract][Full Text] [Related]
12. Bone disorders in cholestatic liver diseases.
Isaia G; Di Stefano M; Roggia C; Ardissone P; Rosina F
Forum (Genova); 1998; 8(1):28-38. PubMed ID: 9514992
[TBL] [Abstract][Full Text] [Related]
13. Bone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy.
Stellon AJ; Davies A; Compston J; Williams R
Gastroenterology; 1985 Nov; 89(5):1078-83. PubMed ID: 4043665
[TBL] [Abstract][Full Text] [Related]
14. Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography.
Borah B; Dufresne TE; Chmielewski PA; Johnson TD; Chines A; Manhart MD
Bone; 2004 Apr; 34(4):736-46. PubMed ID: 15050906
[TBL] [Abstract][Full Text] [Related]
15. Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume.
Fratzl P; Roschger P; Fratzl-Zelman N; Paschalis EP; Phipps R; Klaushofer K
Calcif Tissue Int; 2007 Aug; 81(2):73-80. PubMed ID: 17612779
[TBL] [Abstract][Full Text] [Related]
16. Bone histomorphometry in the pathophysiological evaluation of primary and secondary osteoporosis and various treatment modalities.
Steiniche T
APMIS Suppl; 1995; 51():1-44. PubMed ID: 7669370
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of estrogen therapy in preventing bone loss in primary biliary cirrhosis.
Menon KV; Angulo P; Boe GM; Lindor KD
Am J Gastroenterol; 2003 Apr; 98(4):889-92. PubMed ID: 12738473
[TBL] [Abstract][Full Text] [Related]
18. Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry.
Guichelaar MM; Malinchoc M; Sibonga J; Clarke BL; Hay JE
Hepatology; 2002 Oct; 36(4 Pt 1):895-903. PubMed ID: 12297836
[TBL] [Abstract][Full Text] [Related]
19. Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment.
Miki T; Nakatsuka K; Naka H; Masaki H; Imanishi Y; Ito M; Inaba M; Morii H; Nishizawa Y
J Bone Miner Metab; 2004; 22(6):569-76. PubMed ID: 15490267
[TBL] [Abstract][Full Text] [Related]
20. Lack of osteomalacia in chronic cholestatic liver disease.
Stellon AJ; Webb A; Compston J; Williams R
Bone; 1986; 7(3):181-5. PubMed ID: 3768195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
